Cargando…
Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States
SUMMARY: This retrospective, observational study assessed 2-year persistence and compliance by treatment, route of administration, and dosing frequency in postmenopausal women initiating a new osteoporosis therapy. Two-year persistence and compliance rates were higher in women receiving injectables...
Autores principales: | Durden, Emily, Pinto, Lionel, Lopez-Gonzalez, Lorena, Juneau, Paul, Barron, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329075/ https://www.ncbi.nlm.nih.gov/pubmed/28243883 http://dx.doi.org/10.1007/s11657-017-0316-5 |
Ejemplares similares
-
Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women
por: Balasubramanian, Akhila, et al.
Publicado: (2013) -
Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink
por: Morley, J., et al.
Publicado: (2019) -
Economic Evaluation of Oral Alendronate Therapy for Osteoporosis in Chinese Postmenopausal Women: The Impact of Medication Compliance and Persistence
por: You, Ruxu, et al.
Publicado: (2020) -
Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
por: Suzuki, Takako, et al.
Publicado: (2017) -
Knowledge and compliance towards alendronate therapy among postmenopausal women with osteoporosis in Palestine
por: Radwan, Asma, et al.
Publicado: (2022)